Why is Unjha Formulations Ltd falling/rising?

Feb 12 2026 12:57 AM IST
share
Share Via
On 11-Feb, Unjha Formulations Ltd witnessed a notable uptick in its share price, rising by 3.28% to close at ₹23.29. This gain outpaced the broader sector and reflected a complex interplay of recent performance trends and market positioning.

Recent Price Movement and Market Context

Unjha Formulations Ltd’s gain of ₹0.74 on 11-Feb represents a significant outperformance relative to its sector, with the stock exceeding sector returns by 2.45% on the day. This rise is particularly noteworthy given the broader market context, where the benchmark Sensex showed a modest gain of 0.50% over the past week. The stock’s one-week return of +3.56% comfortably surpasses the Sensex’s performance, signalling a short-term investor interest and positive sentiment.

However, the stock’s performance over longer periods paints a more nuanced picture. Over the past month, Unjha Formulations declined by 2.84%, contrasting with the Sensex’s 0.79% gain. Year-to-date, the stock has fallen 6.84%, a steeper decline than the Sensex’s 1.16% drop. Over the past year, the stock remains down 6.84%, while the Sensex has advanced by 10.41%. These figures suggest that while the stock is currently experiencing a rally, it has faced headwinds in recent months and over the last year.

Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!

  • - Reliable Performer certified
  • - Consistent execution proven
  • - Large Cap safety pick

Get Safe Returns →

Technical Indicators and Trading Activity

From a technical standpoint, the stock’s current price is positioned above its 5-day and 20-day moving averages, indicating short-term strength and potential upward momentum. However, it remains below its 50-day, 100-day, and 200-day moving averages, which suggests that the medium to long-term trend may still be under pressure. This mixed technical picture often reflects a stock in the midst of a recovery phase or consolidation.

Investor participation, as measured by delivery volume, has declined sharply. On 10 Feb, the delivery volume was 1.44 thousand shares, down by 67.88% compared to the five-day average. This drop in investor participation could imply that the recent price rise is driven by a smaller group of traders or speculative interest rather than broad-based buying. Despite this, liquidity remains adequate, with the stock’s traded value supporting reasonable trade sizes, ensuring that investors can enter or exit positions without significant price disruption.

Long-Term Performance and Investor Considerations

Looking beyond the immediate price action, Unjha Formulations Ltd has delivered a robust 40.30% return over three years, slightly outperforming the Sensex’s 38.81% gain in the same period. Over five years, the stock’s appreciation of 158.78% far exceeds the benchmark’s 63.46%, highlighting strong long-term growth potential. This contrast between short-term volatility and long-term gains is important for investors to consider when evaluating the stock’s prospects.

Holding Unjha Formul. from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Conclusion: Why the Stock is Rising Today

The 3.28% rise in Unjha Formulations Ltd’s share price on 11-Feb can be attributed to its outperformance relative to the sector and short-term technical strength. Despite subdued investor participation, the stock’s price movement above key short-term moving averages signals renewed buying interest. This uptick contrasts with the stock’s recent monthly and year-to-date declines, suggesting that investors may be responding to specific catalysts or viewing the current price level as an attractive entry point.

While the stock remains below longer-term moving averages, its strong three- and five-year returns provide a foundation for cautious optimism. Investors should weigh the current positive momentum against the backdrop of recent volatility and reduced trading volumes. Overall, the price rise reflects a short-term rebound within a broader context of mixed performance, underscoring the importance of monitoring both technical signals and fundamental trends when assessing Unjha Formulations Ltd’s investment potential.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News